Best Buy vs Coupang
BBY and CPNG side by side. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How BBY and CPNG compare
Coupang is the larger company, worth 1.2 times as much as Best Buy ($25.2B against $20.6B).
Coupang grew revenue faster over the last twelve months (7.4% versus 1.4% for Best Buy).
Best Buy keeps more of each dollar of sales as profit, with a net margin of 3.0% compared with −3.8% at Coupang.
Best Buy pays a dividend yielding 3.9%; Coupang does not pay one.
Best Buy scores higher on the StockData Score (16 against 3 for Coupang), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | BBY | CPNG |
|---|---|---|
| Size and price | ||
| Market cap | $20.6B | $25.2B |
| Share price | $98.40 | $14.00 |
| Change, 1 year | 30.0% | −50.4% |
| Change, 5 years | −14.3% | −48.9% |
| Beta (5Y) | 0.40 | 1.17 |
| Employees | 82K | 108K |
| StockData Score | ||
| Total score | 16 (better) | 3 |
| Valuation score | 1 (better) | 0 |
| Growth score | 3 (better) | 2 |
| Performance score | 3 (better) | 0 |
| Health score | 5 (better) | 1 |
| Dividend score | 4 (better) | 0 |
| Valuation | ||
| P/E | 16.3× | – |
| P/S | 0.5× (better) | 0.7× |
| P/B | 6.5× | – |
| EV/EBITDA | 7.8× | – |
| P/FCF | 11.7× | – |
| FCF yield | 8.6% (better) | −1.6% |
| Fair value | $95.26 | $13.24 |
| Margin of safety | −3.3% (better) | −5.8% |
| Growth | ||
| Revenue growth (TTM) | 1.4% | 7.4% (better) |
| Revenue growth, 5Y average | −2.5% | 23.6% (better) |
| Net income growth (TTM) | 63.5% (better) | −449% |
| EPS growth (TTM) | 66.3% (better) | −462% |
| EPS growth, 5Y average | −5.9% | – |
| Profitability | ||
| Gross margin | 22.7% | 27.4% (better) |
| Operating margin | 4.1% (better) | −3.4% |
| Net margin | 3.0% (better) | −3.8% |
| FCF margin | 4.2% (better) | −1.1% |
| Return on equity | 43.1% | – |
| Return on invested capital | 55.1% | – |
| Financial health | ||
| Debt / equity | 0.37 | – |
| Net debt / EBITDA | −0.43 | – |
| Interest coverage | 38.0× (better) | −16.3× |
| Current ratio | 1.12 (better) | 0.80 |
| Altman Z-score | 4.25 (better) | 2.17 |
| Piotroski F-score | 7 (better) | 6 |
| Dividends and buybacks | ||
| Dividend yield | 3.9% | – |
| Payout ratio | 63.1% | – |
| Years of dividend growth | 8 | – |
| Dividend growth, 5Y average | 11.6% | – |
| Buyback yield | 0.70% | 4.8% (better) |
| Shareholder yield | 4.6% | 4.8% (better) |
| Ownership | ||
| Held by institutions | 93.9% | 75.3% |
| Held by insiders | 6.7% | 37.0% |
| Insider net buying, 12 months | −$195M | $133M (better) |
| Superinvestors holding | – | 8 |
| Short interest, % of float | 7.8% | 7.0% |
Go deeper
- BBY stock overview
- BBY income statement
- BBY valuation and score
- CPNG stock overview
- CPNG income statement
- CPNG valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.